GL1X · GenesisL1 explorer

MolNFT v1 · #147218 · protein

Nampt co-crystal with inhibitor compound 2

6E68 · Nicotinamide phosphoribosyltransferase: “Nampt co-crystal with inhibitor compound 2”. X-ray diffraction, 2 ligands (HVM, PO4), 7 pockets (best druggability 0.79). MolNFT v1 #147218 on GenesisL1: 3D structure, binding sites and…

PDB
6E68
Type
protein
Length
940 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nicotinamide phosphoribosyltransferase
EC
2.4.2.12
UniProt
P43490
Ligands
HVM, PO4
Pockets
7 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein47142% helix, 19% strandP43490
BNicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein46941% helix, 19% strandP43490

Ligands and binding sites

  • HVM · (2E)-N-{4-[1-(3-aminobenzene-1-carbonyl)piperidin-4-yl]butyl}-3-(pyridin-3-yl)prop-2-enamide · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17580.790.8383HVM, PO4
27290.790.8379PO4, HVM
37380.740.7961empty
4760.360.7715empty
5600.340.7818empty

Interfaces

1 interface between chains.

  • A–B · 4267 Ų buried · 80 hydrogen bonds · protein-protein

Compared structures

  • 6E68 · NAMPT co-crystal with inhibitor compound 2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.